Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XUF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,321
Award facts
- Contract value 100% obligated
- $2,321.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $2,321.10 for Xolair 150 mg/ml syringes by the Defense Logistics Agency's Medical Supply Chain. The contract, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare facilities worldwide.
Xolair (omalizumab), a monoclonal antibody used primarily to treat moderate-to-severe allergic asthma and chronic idiopathic urticaria, represents one of many specialty pharmaceutical products DMS Pharmaceutical Group routinely supplies to military and federal healthcare systems. The contractor's established role as a key supplier within the federal pharmaceutical supply chain, combined with its significant contract portfolio covering everything from oncology treatments to vaccines, positions it to efficiently fulfill this delivery requirement to support DoD medical operations. The relatively modest order value reflects a specific, point-in-time procurement to replenish inventory at designated military healthcare facilities.
Quick answers
Who was awarded contract SPE2DX25F6XUF?
SPE2DX25F6XUF was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 23, 2025.
How much is contract SPE2DX25F6XUF worth?
The government has obligated $2,321 on SPE2DX25F6XUF.
Is contract SPE2DX25F6XUF an order under another contract?
Yes. SPE2DX25F6XUF is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XUF competed?
The extent of competition for SPE2DX25F6XUF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award